NEW YORK, NY / ACCESSWIRE / November 23, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

OLO Shareholders Click Here: https://www.zlk.com/pslra-1/olo-inc-loss-submission-form?prid=33987&wire=1
RAD Shareholders Click Here: https://www.zlk.com/pslra-1/rite-aid-lawsuit-loss-submission-form?prid=33987&wire=1
UIS Shareholders Click Here: https://www.zlk.com/pslra-1/unisys-corporation-lawsuit-submission-form?prid=33987&wire=1

* ADDITIONAL INFORMATION BELOW *

Olo Inc. (NYSE:OLO)

This lawsuit is on behalf of all persons and entities that purchased shares of Olo's Class A common stock between August 11, 2021 and August 11, 2022.
Lead Plaintiff Deadline : November 28, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/olo-inc-loss-submission-form?prid=33987&wire=1

According to the filed complaint, (1) Subway was ending its contract with Olo; (2) Olo's key business metric - active locations - could not continue to grow as defendants touted due to the loss of Subway's business; and (3) as a result of the above, defendants' statements about Olo's business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

Rite Aid Corporation (NYSE:RAD)

RAD Lawsuit on behalf of: investors who purchased April 14, 2022 - September 28, 2022
Lead Plaintiff Deadline : December 19, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/rite-aid-lawsuit-loss-submission-form?prid=33987&wire=1

According to the filed complaint, during the class period, Rite Aid Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) despite representations to the contrary, the number of new members that the Elixir pharmacy benefit management services business was adding during the selling season ending on January 1, 2023 was in material decline; (ii) Rite Aid was likely to recognize a significant charge for the impairment of goodwill related to Elixir due to a decrease in 'lives' covered by Elixir's pharmacy benefit management services business; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Unisys Corporation (NYSE:UIS)

UIS Lawsuit on behalf of: investors who purchased August 3, 2022 - November 7, 2022
Lead Plaintiff Deadline : January 10, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/unisys-corporation-lawsuit-submission-form?prid=33987&wire=1

According to the filed complaint, during the class period, Unisys Corporation made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's 2022 financial guidance was significantly overstated; (ii) accordingly, once the truth was revealed, it was likely that the Company would be required to negatively revise its 2022 financial guidance; (iii) in addition to the foregoing, material weaknesses existed in the Company's internal control over financial reporting; and (iv) as a result of all of the foregoing, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP